Belén Garijo: Merck Has Secured the No. 2 Spot in the Pharma AI Readiness Index - Oncodaily

Belén Garijo: Merck Has Secured the No. 2 Spot in the Pharma AI Readiness Index  Oncodaily

Merck to buy Verona and its lung drug in $10B deal - BioPharma Dive

Merck to buy Verona and its lung drug in $10B deal  BioPharma Dive

Merck to buy lung-disease biotech Verona Pharma for $10 billion | STAT - STAT

Merck to buy lung-disease biotech Verona Pharma for $10 billion | STAT  STAT

Merck Makes Big Respiratory Play With $10B Acquisition of Verona - BioSpace

Merck Makes Big Respiratory Play With $10B Acquisition of Verona  BioSpace

Merck spends $10 billion for Verona, gaining access to its COPD medication - AP News

Merck spends $10 billion for Verona, gaining access to its COPD medication  AP News

Merck & Co. to buy Verona for $10B, gaining fast-launching COPD therapy - FirstWord Pharma

Merck & Co. to buy Verona for $10B, gaining fast-launching COPD therapy  FirstWord Pharma

Merck to Buy Verona Pharma in $10 Billion Deal - The Wall Street Journal

Merck to Buy Verona Pharma in $10 Billion Deal  The Wall Street Journal

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda - Reuters

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda  Reuters

Cancer drug Keytruda maker Merck buys Verona before patent cliff - C&EN

Cancer drug Keytruda maker Merck buys Verona before patent cliff  C&EN

Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma - MedCity ...

Merck Breathes Life Into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma  MedCity News

Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster...

Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre  Fierce Pharma

Merck to Buy Verona for $10 Billion as Patent Cliff Looms - Bloomberg.com

Merck to Buy Verona for $10 Billion as Patent Cliff Looms  Bloomberg.com

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda - Yahoo Finance

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda  Yahoo Finance

QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health - Busine...

QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health  Business Wire

Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B - Investopedia

Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B  Investopedia

Key deals this week: Meta, Boyd Gaming, Merck, Sandstorm Gold, Capgemini and more - Seeking Alpha

Key deals this week: Meta, Boyd Gaming, Merck, Sandstorm Gold, Capgemini and more  Seeking Alpha

Merck Agrees to Acquire Verona Pharma for $10B - Contract Pharma

Merck Agrees to Acquire Verona Pharma for $10B  Contract Pharma

Merck Snags A $10 Billion Buyout - Investor's Business Daily

Merck Snags A $10 Billion Buyout  Investor's Business Daily

Merck to acquire Verona Pharma for $10 billion - Reuters

Merck to acquire Verona Pharma for $10 billion  Reuters

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a F...

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade  Business Wire

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda - CNBC

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda  CNBC

Merck confirms $10B buyout of Verona Pharma (MRK:NYSE) - Seeking Alpha

Merck confirms $10B buyout of Verona Pharma (MRK:NYSE)  Seeking Alpha

Merck will have 'a lot more work to do' after Verona deal - Yahoo Finance

Merck will have 'a lot more work to do' after Verona deal  Yahoo Finance

Merck (MRK) Rises Higher Than Market: Key Facts - Yahoo Finance

Merck (MRK) Rises Higher Than Market: Key Facts  Yahoo Finance

Verona Pharma Stock Jumps 20%. It’s Being Bought for $10 Billion by Merck. - Barron's

Verona Pharma Stock Jumps 20%. It’s Being Bought for $10 Billion by Merck.  Barron's

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma - MarketWatch

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma  MarketWatch

Freshfields Guides Merck's $10B Deal For Verona Pharma - Law360

Freshfields Guides Merck's $10B Deal For Verona Pharma  Law360

Merck to acquire Verona Pharma for $10 billion - Yahoo Finance

Merck to acquire Verona Pharma for $10 billion  Yahoo Finance

Merck Nears $10 Billion Deal for Drugmaker Verona, FT Says - Bloomberg.com

Merck Nears $10 Billion Deal for Drugmaker Verona, FT Says  Bloomberg.com

Merck Buys Verona Pharma: A Good Deal, But M&A Spree Must Continue (NYSE:MRK) - Seeking Alpha

Merck Buys Verona Pharma: A Good Deal, But M&A Spree Must Continue (NYSE:MRK)  Seeking Alpha

Merck strikes $10bn deal for respiratory drugmaker Verona - Financial Times

Merck strikes $10bn deal for respiratory drugmaker Verona  Financial Times

Merck to Buy Verona Pharma for About $10B - Bloomberg.com

Merck to Buy Verona Pharma for About $10B  Bloomberg.com

Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its H...

Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business  Merck Group

CDC vaccine advisers recommend Merck’s RSV therapy for babies - STAT

CDC vaccine advisers recommend Merck’s RSV therapy for babies  STAT

Pharma latest: Merck to acquire Verona, Trump pharma tariffs - Yahoo Finance

Pharma latest: Merck to acquire Verona, Trump pharma tariffs  Yahoo Finance

With gen AI, Merck and McKinsey transform clinical authoring - McKinsey & Company

With gen AI, Merck and McKinsey transform clinical authoring  McKinsey & Company

German pharma firm Merck to acquire UK-based Verona Pharma for $10B - Anadolu Ajansı

German pharma firm Merck to acquire UK-based Verona Pharma for $10B  Anadolu Ajansı

UK: Merck set to acquire Verona Pharma for US$10bn - Investors in Healthcare

UK: Merck set to acquire Verona Pharma for US$10bn  Investors in Healthcare

The Electronics Business of Merck - Merck Group

The Electronics Business of Merck  Merck Group

Merck to acquire Verona Pharma for $10 billion By Reuters - Investing.com

Merck to acquire Verona Pharma for $10 billion By Reuters  Investing.com

Merck & Co.: A Pharma Titan At A Discount (NYSE:MRK) - Seeking Alpha

Merck & Co.: A Pharma Titan At A Discount (NYSE:MRK)  Seeking Alpha

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncyt...

ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season  Merck.com

Merck signs 20-year lease in Delaware following $30M state incentive - Spotlight Delaware

Merck signs 20-year lease in Delaware following $30M state incentive  Spotlight Delaware

Merck Launches Phase 3 Trial of Single-Dose Dengue Vaccine Candidate V181 - Contagion Live

Merck Launches Phase 3 Trial of Single-Dose Dengue Vaccine Candidate V181  Contagion Live

Merck to acquire Verona Pharma for $10 billion - Global Banking | Finance | Review

Merck to acquire Verona Pharma for $10 billion  Global Banking | Finance | Review

UK-based biotech firm Verona snapped up by Merck in $10bn deal - The Times

UK-based biotech firm Verona snapped up by Merck in $10bn deal  The Times

agreement-hub - Merck Group

agreement-hub  Merck Group

Merck Animal Health Investing $895M in De Soto Plant Expansion - Kansas Department of Commerce (....

Merck Animal Health Investing $895M in De Soto Plant Expansion  Kansas Department of Commerce (.gov)

Merck to onshore cancer drug Keytruda in Wilmington - Delaware Business Times

Merck to onshore cancer drug Keytruda in Wilmington  Delaware Business Times

Merck bets $200M on a new type of heart pill - BioPharma Dive

Merck bets $200M on a new type of heart pill  BioPharma Dive

Merck exec says Chernobyl changed the course of her life after her father begged her to leave nuc...

Merck exec says Chernobyl changed the course of her life after her father begged her to leave nuclear physics on his deathbed  Fortune

Addressing the global shortage of TICE BCG - Merck.com

Addressing the global shortage of TICE BCG  Merck.com

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know  Yahoo Finance

Merck takes $200M tariff hit, trimming its gross profits - BioPharma Dive

Merck takes $200M tariff hit, trimming its gross profits  BioPharma Dive

Merck Animal Health, VBMA partner for inaugural business simulation challenge - American Veterina...

Merck Animal Health, VBMA partner for inaugural business simulation challenge  American Veterinary Medical Association

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports - Reuters

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports  Reuters

Merck Animal Health announces $895 million investment in Kansas - Reuters

Merck Animal Health announces $895 million investment in Kansas  Reuters

Merck ‘willing to work’ with Trump administration on price gap between US, international medicine...

Merck ‘willing to work’ with Trump administration on price gap between US, international medicines  Fierce Pharma

Merck to invest $1 billion in new Delaware plant to boost US manufacturing - Reuters

Merck to invest $1 billion in new Delaware plant to boost US manufacturing  Reuters

Merck in talks to acquire respiratory drugmaker Verona Pharma: Report - Medical Dialogues

Merck in talks to acquire respiratory drugmaker Verona Pharma: Report  Medical Dialogues

Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast - Fierce...

Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast  Fierce Pharma

Merck Breaks Ground on $1B Delaware Biologics Center - Engineering News-Record | ENR

Merck Breaks Ground on $1B Delaware Biologics Center  Engineering News-Record | ENR

Our Q1 2025 financial results - Merck.com

Our Q1 2025 financial results  Merck.com

Merck KGaA to buy cancer specialist SpringWorks - Chemistry World

Merck KGaA to buy cancer specialist SpringWorks  Chemistry World

Germany's Merck drops China surcharge on orders after US-China tariff deal - Reuters

Germany's Merck drops China surcharge on orders after US-China tariff deal  Reuters

Inspiring innovation through diversity and inclusion - Merck.com

Inspiring innovation through diversity and inclusion  Merck.com

Merck KGaA fails midphase lupus trial arm, says totality of data support further development - Fi...

Merck KGaA fails midphase lupus trial arm, says totality of data support further development  Fierce Biotech

Delaware commits $30M to entice pharma giant Merck to Wilmington area - Spotlight Delaware

Delaware commits $30M to entice pharma giant Merck to Wilmington area  Spotlight Delaware

Merck and imec Collaborate to Develop Disruptive Microphysiological Systems Platform - Merck Group

Merck and imec Collaborate to Develop Disruptive Microphysiological Systems Platform  Merck Group

Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M - BioSpace

Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M  BioSpace

Merck and Opentrons Partner on Robotic Workstation - Merck Group

Merck and Opentrons Partner on Robotic Workstation  Merck Group

Merck KGaA sheds light on failed portion of phase 2 lupus trial, keeps sights on regulators - Fie...

Merck KGaA sheds light on failed portion of phase 2 lupus trial, keeps sights on regulators  Fierce Biotech

Purdue aims to speed evolution of pharma manufacturing in collaboration with Lilly and Merck - Pu...

Purdue aims to speed evolution of pharma manufacturing in collaboration with Lilly and Merck  Purdue University

Biomanufacturing giant Merck KGaA slimming down French in Martillac plant due to CDMO market tens...

Biomanufacturing giant Merck KGaA slimming down French in Martillac plant due to CDMO market tensions  BioProcess International

Merck KGaA shares data justifying pushing lupus drug into phase 3—despite recent setback - Fierce...

Merck KGaA shares data justifying pushing lupus drug into phase 3—despite recent setback  Fierce Biotech

FDA approves Merck RSV monoclonal antibody shot for infants - CIDRAP

FDA approves Merck RSV monoclonal antibody shot for infants  CIDRAP

Merck & Co. R&D expenditure 2006-2024 - Statista

Merck & Co. R&D expenditure 2006-2024  Statista

Merck KGaA confirms late-stage talks with SpringWorks about $3.5B buyout - Fierce Pharma

Merck KGaA confirms late-stage talks with SpringWorks about $3.5B buyout  Fierce Pharma

Green and sustainable science - Merck.com

Green and sustainable science  Merck.com

Merck CEO Calls Diversity ‘Core’ to Operations as Anti-DEI Measure Is Defeated - BioSpace

Merck CEO Calls Diversity ‘Core’ to Operations as Anti-DEI Measure Is Defeated  BioSpace

Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion - Reuters

Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion  Reuters

Merck & Co. pens $200M upfront deal for Hengrui's midstage heart disease med - Fierce Biotech

Merck & Co. pens $200M upfront deal for Hengrui's midstage heart disease med  Fierce Biotech

NJ-Based Merck Breaks Ground on $1B Delaware Manufacturing Facility - New Jersey Business & Indus...

NJ-Based Merck Breaks Ground on $1B Delaware Manufacturing Facility  New Jersey Business & Industry Association

Merck inks $493M biobucks deal to use Cyprumed's tech to create oral peptides - Fierce Biotech

Merck inks $493M biobucks deal to use Cyprumed's tech to create oral peptides  Fierce Biotech

Merck’s anti-RSV antibody expands protection for infants - Nature

Merck’s anti-RSV antibody expands protection for infants  Nature

Merck's potential blockbuster cholesterol pill succeeds in late-stage studies - Reuters

Merck's potential blockbuster cholesterol pill succeeds in late-stage studies  Reuters

m-trust-zebra-cooperation - Merck Group

m-trust-zebra-cooperation  Merck Group

Merck lowers profit outlook, partly due to $200 million expected tariff hit - CNBC

Merck lowers profit outlook, partly due to $200 million expected tariff hit  CNBC

Merck KGaA keeps schtum on ongoing SpringWorks talks - FirstWord Pharma

Merck KGaA keeps schtum on ongoing SpringWorks talks  FirstWord Pharma

Merck to Acquire Verona Pharma for $10 Billion in Bid to Cushion "Patent Cliff" Impact - Mitrade

Merck to Acquire Verona Pharma for $10 Billion in Bid to Cushion "Patent Cliff" Impact  Mitrade

Pimicotinib Topline Results | Merck - Merck Group

Pimicotinib Topline Results | Merck  Merck Group

Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks - Fierce Ph...

Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks  Fierce Pharma

Merck KGaA cautious on 2025 profit on currency effects, tariff uncertainty - Reuters

Merck KGaA cautious on 2025 profit on currency effects, tariff uncertainty  Reuters

CRISP signs Merck for $900M campus in Delaware - Delaware Business Times

CRISP signs Merck for $900M campus in Delaware  Delaware Business Times

US FDA approves Merck's RSV antibody for infants - Reuters

US FDA approves Merck's RSV antibody for infants  Reuters

Merck's Shizuoka Investments Exceed €120M with New Advanced Materials Center - Merck Group

Merck's Shizuoka Investments Exceed €120M with New Advanced Materials Center  Merck Group

Merck KGaA pays $85M to nab global rights for Abbisko's rare tumor drug after phase 3 win - Fierc...

Merck KGaA pays $85M to nab global rights for Abbisko's rare tumor drug after phase 3 win  Fierce Biotech

Merck posts higher profit, puts tariffs cost at $200 million - Reuters

Merck posts higher profit, puts tariffs cost at $200 million  Reuters

Two of Kennedy’s New ACIP Picks Were Paid Expert Witnesses in Merck Vaccine Cases - BioSpace

Two of Kennedy’s New ACIP Picks Were Paid Expert Witnesses in Merck Vaccine Cases  BioSpace

Merck Votes Overwhelmingly in Support of DEI Amid Backlash - Sustainability Magazine

Merck Votes Overwhelmingly in Support of DEI Amid Backlash  Sustainability Magazine